Manger B - Search Results

1

Paraneoplastic syndromes in rheumatology.

Manger B, Schett G. Manger B, et al. Nat Rev Rheumatol. 2014 Nov;10(11):662-70. doi: 10.1038/nrrheum.2014.138. Epub 2014 Aug 19. Nat Rev Rheumatol. 2014. PMID: 25136782 Review.

2

The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis.

Bleil L, Manger B, Winkler TH, Herrman M, Burmester GR, Krapf FE, Kalden JR. Bleil L, et al. Among authors: manger b. J Rheumatol. 1991 Aug;18(8):1199-206. J Rheumatol. 1991. PMID: 1941824

3

Biologic agents in the treatment of inflammatory rheumatic diseases.

Kalden JR, Manger B. Kalden JR, et al. Among authors: manger b. Curr Opin Rheumatol. 1995 May;7(3):191-7. doi: 10.1097/00002281-199505000-00006. Curr Opin Rheumatol. 1995. PMID: 7612410 Review.

4

Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Pirner K, Rascu A, Nürnberg W, Rubbert A, Kalden JR, Manger B. Pirner K, et al. Among authors: manger b. Rheumatol Int. 1994;14(4):169-74. doi: 10.1007/BF00579703. Rheumatol Int. 1994. PMID: 7871336

5

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.

Manger K, Kalden JR, Manger B. Manger K, et al. Among authors: manger b. Br J Rheumatol. 1996 Jul;35(7):669-75. doi: 10.1093/rheumatology/35.7.669. Br J Rheumatol. 1996. PMID: 8670602 Clinical Trial.

6

99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis.

Meusser S, Rubbert A, Manger B, Bock E, Platsch G, Feistel H, Engelhardt A, Wolf F, Kalden JR. Meusser S, et al. Among authors: manger b. Rheumatol Int. 1996;16(1):37-42. doi: 10.1007/BF01419953. Rheumatol Int. 1996. PMID: 8783421

7

Biologic agents in the treatment of inflammatory rheumatic diseases.

Kalden JR, Manger B. Kalden JR, et al. Among authors: manger b. Curr Opin Rheumatol. 1996 May;8(3):195-200. doi: 10.1097/00002281-199605000-00005. Curr Opin Rheumatol. 1996. PMID: 8796978 Review.

8

NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy.

Kalden-Nemeth D, Grebmeier J, Antoni C, Manger B, Wolf F, Kalden JR. Kalden-Nemeth D, et al. Among authors: manger b. Rheumatol Int. 1997;16(6):249-55. doi: 10.1007/BF01375657. Rheumatol Int. 1997. PMID: 9106936 Clinical Trial.

9

Biologic agents in the treatment of inflammatory rheumatic diseases.

Kalden JR, Manger B. Kalden JR, et al. Among authors: manger b. Curr Opin Rheumatol. 1997 May;9(3):206-12. doi: 10.1097/00002281-199705000-00006. Curr Opin Rheumatol. 1997. PMID: 9204255 Review.

10

[Arthralgia, sudden drop in sedimentation rate and hour-glass nails].

Manger B, Nüsslein H. Manger B, et al. Med Klin (Munich). 1997 Oct 15;92(10):604. doi: 10.1007/BF03044786. Med Klin (Munich). 1997. PMID: 9446008 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results